CG Oncology reported a quarterly loss of $0.90 per share, worse than the Zacks Consensus Estimate of a $0.70 loss. The loss also widened versus the $0.54 per share reported a year ago.
CG Oncology reported a quarterly loss of $0.90 per share, worse than the Zacks Consensus Estimate of a $0.70 loss. The loss also widened versus the $0.54 per share reported a year ago.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
